AWK

American Water Works is the archetypal wide-moat regulated utility: the largest, most geographically diverse US water/wastewater provider serving ~14 million people across 24 states, with 3.6M regulated customers. The quality shows in the numbers — FY2025 operating margin of 36.7% and net margin of 21.7% are exceptional and stable, and revenue has compounded from $3.91B (2021) to $5.12B (2025). Critically, the MD&A confirms this growth is durable and low-risk: of the $427M FY2025 revenue increase, $406M came from authorized rate increases and infrastructure surcharges (recovering capital investment), plus $49M from acquisitions and organic growth. This is regulator-blessed, rate-base-driven compounding, not cyclical demand — billed water volumes were actually flat-to-down (333B gallons vs 336B in 2024), yet revenue rose because rates did. That is the entire investment appeal.

The problem is price versus what you get. At $136.86 the stock trades at 24.1x FY2025 EPS of $5.69 (adjusted $5.64), a rich multiple for a business whose diluted EPS grew only 5.6% and whose ROE is a modest 10.3%. The growth engine also consumes cash: capex of $3.13B vastly exceeds operating cash flow of $2.06B, so the plan is permanently funded with external capital. That dependence is now costlier — the MD&A repeatedly flags 'higher financing costs,' a $76M jump in Regulated other expense 'primarily due to higher interest expense from the issuance of incremental long-term debt,' and a $141M depreciation increase from plant placed in service. The balance sheet reflects the strain: current portion of debt jumped 80.7% to $1.59B, current liabilities ($4.75B) far exceed current assets ($2.19B), and cash is a razor-thin $98M. None of this is alarming for a regulated utility with reliable rate recovery, but it caps returns and leaves no margin of safety at this multiple.